Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy

BACKGROUND: A high multiple sclerosis activity while on alemtuzumab is rather uncommon compared to moderate-efficacy drugs. The purpose of this case report is to present a case of a 37-year-old female patient with bronchial asthma and no other medical history, whose disease activity required switchi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vališ, Martin, Ryška, Pavel, Halúsková, Simona, Klímová, Blanka, Pavelek, Zbyšek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240916/
https://www.ncbi.nlm.nih.gov/pubmed/32438901
http://dx.doi.org/10.1186/s12883-020-01789-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240916/
https://www.ncbi.nlm.nih.gov/pubmed/32438901
http://dx.doi.org/10.1186/s12883-020-01789-y

Ejemplares similares